Credit Agricole’s Bristol-Myers Squibb BMY Stock Holding History

Credit Agricole’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.6M	Buy	175,000 +50,000	+40%	+$2.91M	0.03%	384
2025 Q4	$6.74M	Buy	+125,000	New	+$6.01M	0.02%	517
2025 Q1	$6.1M	Sell	100,000 -50,000	-33%	-$2.91M	0.02%	499
2024 Q4	$8.48M	Hold	150,000	–	–	0.02%	433
2024 Q3	$7.76M	Hold	150,000	–	–	0.03%	339
2024 Q2	$6.23M	Buy	150,000 +50,000	+50%	+$2.24M	0.03%	323
2024 Q1	$4.83M	Hold	100,000	–	–	0.05%	260
2023 Q4	$5.13M	Buy	+100,000	New	+$5.25M	0.06%	209

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Agricole's BMY Position: Q1 2026 in Review

Credit Agricole reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, selling an estimated $6.16M and leaving 785,099 shares worth $47.6M. The position accounts for 0.13% of the portfolio, ranked #127.

Credit Agricole first reported a position in BMY in Q3 2013 and has held it in 50 quarters since. The position peaked at $145M in Q1 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Credit Agricole held 785,099 shares of Bristol-Myers Squibb worth $47.6M as of Q1 2026.
Credit Agricole sold 105,679 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.16M.
Bristol-Myers Squibb made up 0.13% of Credit Agricole's portfolio in Q1 2026, its #127 holding.
Credit Agricole first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 50 quarters since.
Credit Agricole's Bristol-Myers Squibb position peaked at $145M in Q1 2016.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.